Auxilium Pharmaceuticals, Inc.
Pharmaceutical firm raises $40.4M in private placement
Published in Lab Business Week, July 31st, 2005
Auxilium Pharmaceuticals, Inc., (AUXL) announced that it has entered into definitive agreements with institutional and other accredited investors, including existing stockholders and affiliated entities, for the private placement of approximately 8.2 million shares of common stock at a price of approximately $4.90 per share, together with warrants to purchase approximately 2.06 million additional shares of common stock at an exercise price of $5.84 per share, for a total purchase price of $40.4 million.
The private placement is expected to close on or before July 13, 2005, and is subject to certain closing conditions.
Deutsche Bank Securities, Inc.,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-07-31)
More Articles from Lab Business Week
- Aastrom Biosciences, Inc.
Biotech company added to Russell 3000 index - Aeolus Pharmaceuticals, Inc.
Pharmaceutical company announces capital infusion from shareholders - Alcon, Inc.
Ophthalmology company provides $1M grant for blindness prevention - Ascentia Biomedical Corporation
Pharmaceutical firm begins trading on OTC Pink Sheets - Avanir Pharmaceuticals
Pharmaceutical company files shelf registration statement - Biosite Incorporated
Diagnostics company reports new option grants - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
